HSBC upgraded Occidental (OXY) to Buy from Hold with a price target of $55, up from $48. The proposed OxyChem sale accelerates the company’s debt retirement and significantly pulls forward its share buybacks, the analyst tells investors in a research note. The firm believes the share pullback from disappointment in the OxyChem sale price “presents a great buying opportunity.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OXY:
- Occidental Petroleum’s Strategic Moves: Enhancing Shareholder Value through Divestment and Integration
- Morning Wrap-Up: Thursday’s Biggest Stock Market Stories!
- Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
- M&A: Occidental Stock (OXY) Plunges as Warren Buffett Pays $9.7B to Buy Chemical Division
- Video: Credit bureaus sink after FICO bring Scores directly to customers
